Sarah Abrams

Over recent years, many companies have pursued paths for going public as an alternative to a traditional IPO, including, for example, through a reverse merger, and or a SPAC transaction. In the following guest post, Sarah Abrams, Head of Claims Baleen Specialty, a division of Bowhead Specialty, takes a look at these alternatives, and considers what these kinds of transactions may mean in terms of potential D&O liability exposure. I would like to thank Sarah for allowing me to publish her article as a guest post on this site. I welcome guest post submissions from responsible authors on topics of interest to this site’s readers. Please contact me directly if you would like to submit a guest post. Here is Sarah’s article.Continue Reading Guest Post: Backing Into an IPO

As numerous commentators have noted, one of the most distinctive litigation developments over the last twelve months has been the emergence of U.S. securities litigation against Chinese companies that obtained their listings on U.S. exchanges that a “reverse merger” with a publicly traded U.S. shell company.

Given the prominence of these issues, I